By Chris Reidy | Globe Staff-- December 01, 2011
H3 Biomedicine Inc., a start-up focused on cancer treatments based on genetics, is officially unveiling its new 24,000-square-foot office in Cambridge today, another sign of growth at Kendall Square.
H3 Biomedicine currently employs 30 staffers and it looks to add another 40 over the next 12 months, company president and chief executive Markus Warmuth, M.D., said.
